Traws Pharma, Inc.TRAWNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+126.1%
5Y CAGR+28.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+126.1%/yr
vs -52.3%/yr prior
5Y CAGR
+28.3%/yr
Recent acceleration
Acceleration
+178.5pp
Accelerating
Percentile
P96
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q2 2025 | 85.37% |
| Q4 2024 | -63.78% |
| Q2 2024 | 45.43% |
| Q4 2023 | 11.13% |
| Q2 2023 | 5.52% |
| Q4 2022 | -37.85% |
| Q2 2022 | -6.44% |
| Q4 2021 | 11.32% |
| Q2 2021 | 30.22% |
| Q4 2020 | -0.52% |
| Q2 2020 | -15.13% |
| Q4 2019 | 0.44% |
| Q2 2019 | 7.38% |
| Q4 2018 | -1.73% |
| Q2 2018 | 10.37% |
| Q4 2017 | -0.12% |
| Q2 2017 | -19.25% |
| Q4 2016 | 16.52% |
| Q2 2016 | -384.58% |
| Q4 2015 | 87.49% |
| Q2 2015 | 24.57% |
| Q4 2014 | 20.42% |
| Q2 2014 | -2.41% |
| Q4 2013 | -25.78% |
| Q2 2013 | -713.91% |
| Q4 2012 | 82.08% |
| Q2 2012 | 0.00% |